SGLT2i Safety in Acute Heart Failure Confirmed by New Data :

Results of the DICTATE-AHF randomized trial that tested starting dapagliflozin for patients hospitalized with acute heart failure confirmed the safety and benefit of this guideline-directed strategy.

Related Keywords

Tennessee , United States , Massachusetts , Amsterdam , Noord Holland , Netherlands , Boston , Zachary Cox , Stephend Wiviott , Harvard Medical School , Boehringer Ingelheim , European Society Of Cardiology , Astrazeneca , Lipscomb University College Of Pharmacy , European Society , Lipscomb University College , Heart Failure , Acute Heart Failure , Acute Hf , Hypertension , Heart , Cardiomyopathy , Diuretics , Cardiovascular Imaging , Ardiac Imaging , V Imaging , Hospitals , Clinical Guidelines , Guidelines , Cox , Yclooxygenase , Sglt2 Inhibitors , Odium Glucose Transporter 2 Inhibitors , Odium Glucose Co Transporter 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , ,